Geriatric and Oncologic Assessment Before Treatment

N/AUnknownNCT02671994

Odense University Hospital114 enrolled

Overview

In a randomized controlled trial, the investigators wish to investigate, if oncologic treatment decision based on G8 screening followed by geriatric assessment and subsequent MDT, if needed, in older frail patients with gynaecologic and urologic cancer is superior to standard assessment (PS and clinical assessment) in oncologic treatment decision.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

OTHER

Masking

NONE

Enrollment

114

Conditions

Cancer

Interventions

G8 screeningOTHER

Geriatric assessmentOTHER

Eligibility

Sex: ALLMin age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Histologically verified gynaecologic cancer (ovarian, uterine, or cervical cancer) or urologic cancer (prostate, bladder, or kidney cancer). * Suited for first line medical oncologic treatment with chemotherapy and/or targeted therapy. * Age ≥ 70 years. * Understands, speaks, and writes Danish. * Signed informed consent. Exclusion Criteria: * Previous cancer diagnosis except for carcinoma in situ of the cervix or skin cancer other than malignant melanoma. * Previous chemotherapy and/or targeted therapy for current cancer diagnosis. * Previous radiation therapy or concomitant radiotherapy for current cancer diagnosis. * Surgery within the last 4 weeks.

Locations (1)

Odense University Hospital

Odense, Denmark

Outcomes

Primary Outcomes

Feasibility of planned oncologic treatment (number of participants, who complete the planned oncologic treatment)

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.